COSCIENS Biopharma Inc. , a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United States, and internationally.
Cosciens Biopharma stock last closed at $3.51, up 11.96% from the previous day, and has decreased 55.06% in one year. It has overperformed other stocks in the Biotechnology industry by 0.22 percentage points. Cosciens Biopharma stock is currently +79.08% from its 52-week low of $1.96, and -68.38% from its 52-week high of $11.10.
At the moment, there are 3.14M shares of CSCI outstanding. The market capitalization of CSCI is $11.02M. In the last 24 hours, 9632 CSCI shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy CSCI shares.
Based on our analysis, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you need to fill out some personal details so you can buy CSCI today.
Now that you have filled out your info on the best stock broker app, you can securely and quickly fund your account:
Watch the video below for more details depositing money into your investment account.
Once you have figured out the best place to buy Cosciens Biopharma stock, it's critical to research their stock before you invest, so you truly understand the risk and upside.
WallStreetZen was created to help average investors perform more in-depth fundamental analysis.
You can see all of the due diligence checks on CSCI's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge CSCI's intrinsic value.
Using relative valuations ratios:
You can access additional valuation analysis on CSCI's stock here.
Last year, CSCI revenue was $9.59M. During the past 5 year, CSCI's revenue has increased by 78.3% per year. This was faster than the Biotechnology industry average of 45.47%.
You can research CSCI's earnings and revenue performance here.
Over the past year, insiders at CSCI have not bought or sold any shares.
Dig into more about who owns CSCI stock here.
No, Cosciens Biopharma doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other investors have to say.
You have two primary options:
Click the Open Trade button and eToro will place your order.
If you want more info about buying stocks on eToro, click the how to video below:
Now that you own some CSCI stock, you'll want to keep up with your shares.
Put CSCI on a watchlist to get notified of important updates regarding your CSCI stock.
To summarize, here are the 6 steps for buying Cosciens Biopharma stock:
If you need a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to get the latest news on your investment in Cosciens Biopharma, create a watchlist today.